ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,481, issued on Feb. 17, was assigned to The Jackson Laboratory (Bar Harbor, Maine).
"Molecular targets for addiction" was invented by Elissa Chesler (Bar Harbor, Maine) and Michael Saul (Bar Harbor, Maine).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for the treatment or prevention of certain disorders and conditions, for example, addiction using an agent to modulate 5-hydroxytryptamine 1D receptor (HTR1D) activity and/or expression. Also provided are methods for screening a candidate to determine if the candidate is suitable for the therapies disclosed herein."
The patent was filed on Dec. 18, 2020, un...